Product NDC: | 0703-2856 |
Proprietary Name: | Propofol |
Non Proprietary Name: | Propofol |
Active Ingredient(s): | 10 mg/mL & nbsp; Propofol |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, EMULSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0703-2856 |
Labeler Name: | Teva Parenteral Medicines, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075102 |
Marketing Category: | ANDA |
Start Marketing Date: | 20070621 |
Package NDC: | 0703-2856-04 |
Package Description: | 25 VIAL, SINGLE-USE in 1 TRAY (0703-2856-04) > 20 mL in 1 VIAL, SINGLE-USE (0703-2856-01) |
NDC Code | 0703-2856-04 |
Proprietary Name | Propofol |
Package Description | 25 VIAL, SINGLE-USE in 1 TRAY (0703-2856-04) > 20 mL in 1 VIAL, SINGLE-USE (0703-2856-01) |
Product NDC | 0703-2856 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Propofol |
Dosage Form Name | INJECTION, EMULSION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20070621 |
Marketing Category Name | ANDA |
Labeler Name | Teva Parenteral Medicines, Inc. |
Substance Name | PROPOFOL |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | General Anesthesia [PE],General Anesthetic [EPC] |